DFTX

Conviction 0HealthcareScan · Thu, Sep 24, 2026

Definium Therapeutics, Inc. (DFTX) closed at $36.70 (-2.52%) on Sep 24, 2026. Price is below its 50-day. RSI(14) 40, -24.3% from its 52-week high, +138.6% year to date. Sector: Healthcare · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.

DFTX$36.70-2.52%

ResistanceSupportVol 14Insider sell

Vol MA14 2.45M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

WSB mentions · 24h changelatest +100.00%· 2 mentions

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Definium Therapeutics, Inc.MEDICINAL CHEMICALS & BOTANICAL PRODUCTSwww.definiumtx.com ↗

Price36.70

Change-2.52%

Gap-0.54%

Rel volume0.85×

Avg volume2.24M

Avg $ vol87M

SMA 2038.86

SMA 5041.87

SMA 200—

Price vs 50-12.35%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 43.09

RSI (14)40

MACD hist-0.00

MACD crossbear · 0d

Stoch %K / %D10 / 25

ADX (14)15

+DI / −DI24 / 26

RSI divergence—

MACD divergence—

ATR %6.00%

ADR %5.02%

52w high48.45

52w low15.05

From 52w high-24.25%

Above 52w low+143.85%

New 52w highNo

SqueezeOff

Bollinger width16.16%

%B0.16

Donchian pos8.52%

Donchian high44.97

Donchian low35.93

AVWAP (52w high)41.45

vs AVWAP high-11.46%

AVWAP (52w low)31.34

vs AVWAP low+17.12%

OBV trendFlat

Chaikin MF (20)-0.26

Today vs 20d0.85×

Avg vol (14d)2.45M

Avg vol (20d)2.24M

Avg $ vol (20d)87M

Market cap4.93B

RS Rating—

RS 3m (vs SPY)-22.55%

RS 6m (vs SPY)+81.88%

RS line new highNo

Trend template—

Technical rank50.4

1 week-5.12%

1 month-18.10%

3 months-18.06%

6 months+98.70%

1 year—

YTD+138.62%

P/E-26.83

P/B5.37

P/S—

P/FCF—

EPS-2.06

Div yield—

ROE-20.01%

ROA-16.51%

Debt/Eq0.04

Current6.95

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-69.12%

Price target72.00

Target upside96.19%

Analyst ratingBuy

Institutional90.18%

Ent. value4.31B

Revenue—

Net income-158.99M

Gross profit—

Free cash flow—

IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS

ExchangeNasdaq

Shares out109.07M

Employees106

ListedTue, Mar 3, 2020

Free float90.87M

Float %92.3%

Short interest9.84M

Days to cover5.6d

Short volume44.7%

Squeeze score50 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.44 vs −$0.55

Last surprise-161.8% miss

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank50.4 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance48.63

Support36.94

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DFTX

All disclosures →

No recent disclosed trades by Congress in DFTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DFTX · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
Barrow Robert Chief Executive Officer · Common Shares · 2026-09-14	Grant	750K	—	2026-09-14	2026-09-14
Barrow Robert Chief Executive Officer · Common Shares · 2026-08-12	Grant	375K	—	2026-08-12	2026-08-12
Roberts Brandi Chief Financial Officer · Common Shares · 2026-08-12	Grant	62.5K	—	2026-08-12	2026-08-12
Wiley Matthew T. Chief Commercial Officer · Common Shares · 2026-08-12	Grant	62.5K	—	2026-08-12	2026-08-12
Sullivan Mark Chief Legal Officer · Common Shares · 2026-08-12	Grant	62.5K	—	2026-08-12	2026-08-12
Karlin Daniel Chief Medical Officer · Common Shares · 2026-08-12	Grant	100K	—	2026-08-12	2026-08-12
Barrow Robert Chief Executive Officer · Common Shares · 2026-06-25	Sell	29.21K	$1.3M	2026-06-25	2026-06-26
Barrow Robert Chief Executive Officer · Common Shares · 2026-06-22	Grant	375K	—	2026-06-22	2026-06-22
Karlin Daniel Chief Medical Officer · Common Shares · 2026-06-22	Grant	100K	—	2026-06-22	2026-06-22
Sullivan Mark Chief Legal Officer · Common Shares · 2026-06-22	Grant	62.5K	—	2026-06-22	2026-06-22

SEC filings

EDGAR filings in DFTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.